Clinical Trial Update: Phase 1b Study Investigating Safety & Immunogenicity of TDV Given Intradermally by Needle or Needle-Free PharmaJet Injector [Phase 1]

View source ↗

Summary

Phase 1b study assessing safety and immunogenicity of TDV administered intradermally via needle or needle-free injector in healthy volunteers; completed with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Healthy Volunteers

Drugs mentioned

• TDV (Takeda dengue vaccine)

Snippet

Sponsor: Takeda | Conditions: Healthy Volunteers | Phase 1 | Status: COMPLETED | Results posted: 2017-01-05